聚焦IL-6:从心血管病理生理学到治疗
Alberto Preda1, Amedeo Tirandi2,3, Giulio Leo4
1De Gasperis Cardio Center, Electrophysiology Unit, Niguarda Hospital, Milan, Italy.
European journal of clinical investigation
|December 4, 2025
概括
洲际蛋白-6 (IL-6) 在心血管疾病 (CVD) 中具有双重作用,在急性方面具有保护性,但在慢性方面具有有害性. 针对慢性IL-6激活可能为管理心血管疾病和残留炎症风险提供新的治疗策略.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 介乐-6 (IL-6) 是一种参与免疫和代谢调节的细胞因子.
- 持续的IL-6激活,特别是通过跨信号,有助于内皮功能障碍,动脉样硬化和心肌纤维化.
研究的目的:
- 审查IL-6在心血管疾病 (CVD) 中的作用的证据.
- 探索IL-6的分子通路,预后价值和心血管疾病的治疗潜力.
主要方法:
- 实验,遗传和临床证据的全面审查.
- 对全基因组关联研究和临床试验的分析,包括针对IL-6的干预措施.
主要成果:
- 急性IL-6信号在心肌梗塞中具有保护作用,而慢性激活会导致心肌不适应性变化.
- IL-6促进血管炎症,单细胞招募,凝血和纤维化,与冠状动脉疾病,中风和心房动有因果关系.
- 升高的IL-6预测急性冠状动脉综合征和心力衰竭的不良结果;IL-6抑制显示出有前途.
结论:
- IL-6具有双重作用:保护性/致病性和急性/慢性.
- 慢性IL-6将炎症和代谢问题与心血管损伤联系在一起,需要特定于环境的疗法.
- 目前正在进行的试验将确定IL-6阻断是否可以整合到心血管疾病预防和管理中.
相关概念视频
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K
Psychoneuroimmunology: Cardiovascular Disease
368
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
A key area of focus in PNI is the relationship between stress and coronary...
368
Regulation of the Cardiovascular System
3.6K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.6K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235


